{"disease":{"id":"norovirus-prevention","name":"norovirus prevention"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02142504","title":"Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":454,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT02038907","title":"Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":420,"lead_sponsor_name":"Takeda","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}